Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on August 21, 2009. The filing discloses the approval of a new employment agreement for Larry G. Stambaugh, the Company's President, Chief Executive Officer, and Chairman of the Board. The agreement, effective August 1, 2009, formalizes his compensation and benefits following his previous roles as a consultant and subsequent election to executive positions.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or liquidity metrics. The document focuses exclusively on executive compensation arrangements.
Material Changes and Compensation Terms
The filing details the following material terms of Mr. Stambaugh's employment agreement:
- Base Salary: $360,000 annually, subject to annual increases at the Committee's discretion.
- Annual Bonus: Eligible for a discretionary bonus of up to 60% of his annualized base salary.
- Financing Incentive: A one-time payment of $125,000 if the Company raises an aggregate of $5,000,000 via equity or convertible debt between March 30, 2009, and the end of the Term.
- Stock Option Grant: Entitlement to an incentive stock option for 670,000 shares on October 1, 2009 (or sooner if permitted by debt restrictions). The exercise price will be the greater of fair market value or the price allowable under existing convertible debentures. Vesting is 33 1/3% upon grant, with the remainder vesting in equal installments over the first and second anniversaries.
- Severance: Upon termination without cause or constructive discharge, Mr. Stambaugh is entitled to six months' base salary (if within the first 12 months) or twelve months' base salary (if after the first 12 months), plus one year of health insurance coverage.
Correction of Prior Disclosures
The filing corrects a prior disclosure error regarding a warrant for 500,000 shares granted to Mr. Stambaugh on December 10, 2008. Previous reports incorrectly stated the warrant vested over three years in equal proportions. The Board confirmed the correct vesting schedule is one-third (1/3) on the grant date, with the remaining two-thirds (2/3) vesting in equal installments on the first and second anniversaries.
Investor Verification Checklist
- Verify the Company's ability to raise the $5,000,000 required to trigger the $125,000 financing incentive payment.
- Review the terms of the existing convertible debentures (dated September 27, 2007, and May 30, 2008) to determine if they restrict the October 1, 2009, stock option grant.
- Confirm the impact of the corrected vesting schedule for the 500,000 share warrant on prior financial reporting and expense recognition.
- Assess the dilution impact of the new 670,000 share option grant and the existing 500,000 share warrant.